Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Electronic comment system

This article was originally published in The Tan Sheet

Executive Summary

FDA will no longer accept electronic comments through its Web site beginning Jan. 15. Rather, it will accept electronic comments only through the Federal Dockets Management System - a full-featured management system and "one-stop site to search, view and download documents," the agency says in notice scheduled to appear in the Jan. 14 Federal Register. The switch is part of the president's e-rulemaking initiative. Public can access the system at 1http://www.Regulations.gov. The agency will move all dockets managed in the current system to the new system in the next few months...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101245

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel